Loading…
Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010
Legislative Progress
Introduced
February 26, 2009
Latest Action
November 15, 2010
Primary Sponsor
Doris O. MatsuiDemocratic(CA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
100pct
627d open
vs 6,490 other HR bills in the 111th — cohort avg 44d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2010 · fourth_quarter · Medical/Disease Research/Clinical Labs
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081) Use of Cesium-137 Chloride (CsCl) sources in biomedical research
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
2010 · fourth_quarter · Health Issues
Healthcare for cancer patients , C.W. Bill Young Transplatation Program, National Cord Blood Inventory, H.R. 1230 Bone Marrow Failure Disease Research and Treatment Act of 2009, S 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all healthcare bill, SRES 205/HCR 150 African American Bone Marrow Awareness month, Americans Affordable Health Choices Act of 2009, American Healthy Future Act of 2009, H.R.6081 and S.3751, The Stem Cell Therapeutic & Research Act 2010
Client expense: $103,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Budget/Appropriations
H.R.-No Bill#/S. 3686, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research H.R.-No Bill#/S. 3800, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · fourth_quarter · Health Issues
H.R.-No Bill#/S. 3686, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research H.R.-No Bill#/S. 3800, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · fourth_quarter · Science/Technology
H.R.-No Bill#/S. 3686, Labor-HHS-Education Appropriations Bill, FY 2011 , biomedical research H.R.-No Bill#/S. 3800, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R.-No Bill#/S. 3686, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research H.R.-No Bill#/S. 3800, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · fourth_quarter · Medical/Disease Research/Clinical Labs
Labor, HHS, Education Appropriations bills; hematology and hematology/oncology public health and research issues; HR 1230 Bone Marrow Failure Disease Research and Treatment Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · third_quarter · Medical/Disease Research/Clinical Labs
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research Proposed Revisions to NIH COI Policy Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081)
Client expense: $30,000 · Firm income: Not reported
2010 · third_quarter · Health Issues
Healthcare for cancer patients , C.W. Bill Young Transplatation Program, National Cord Blood Inventory, H.R. 1230 Bone Marrow Failure Disease Research and Treatment Act of 2009, S 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all healthcare bill, SRES 205/HCR 150 African American Bone Marrow Awareness month, Americans Affordable Health Choices Act of 2009, American Healthy Future Act of 2009, H.R.6081 and S.3751, The Stem Cell Therapeutic & Research Act 2010 HR 1230
Client expense: $98,624 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
H.R.-No Bill#/S. 3686, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research H.R.-No Bill#/S. 3800, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · third_quarter · Medical/Disease Research/Clinical Labs
H.R.-No Bill#/S. 3686, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research H.R.-No Bill#/S. 3800, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · third_quarter · Budget/Appropriations
H.R.-No Bill#/S. 3686, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research H.R.-No Bill#/S. 3800, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · third_quarter · Science/Technology
H.R.-No Bill#/S. 3686, Labor-HHS-Education Appropriations Bill, FY 2011 , biomedical research H.R.-No Bill#/S. 3800, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · third_quarter · Medical/Disease Research/Clinical Labs
Labor, HHS, Education Appropriations bills; hematology and hematology/oncology public health and research issues; HR 1230 Bone Marrow Failure Disease Research and Treatment Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · second_quarter · Medical/Disease Research/Clinical Labs
Stem Cell Research Advancement Act (H.R. 4808) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Electronic Prescription for Controlled Substances
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2010 · second_quarter · Health Issues
Healthcare for cancer patients, C.W. Bill Young Transplantation Program, National Cord Blood Inventory, H.R. 1230 Bone Marrow Failure Disease Research and Treatment Act of 2009, S 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all healthcare bill, SRES 205/HCR 150 African American Bone Marrow Awareness Month, Americans Affordable Health Choices Act of 2009, American Healthy Future Act of 2009
Client expense: $115,663 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Science/Technology
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011 , biomedical research No Bill#, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · second_quarter · Medical/Disease Research/Clinical Labs
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research No Bill#, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · second_quarter · Budget/Appropriations
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research No Bill#, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · second_quarter · Health Issues
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research No Bill#, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · second_quarter · Medical/Disease Research/Clinical Labs
Labor, HHS, Education Appropriations bills; hematology and hematology/oncology public health and research issues; Health Reform Legislation; HR 1230 Bone Marrow Failure Disease Research and Treatment Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · first_quarter · Health Issues
Healthcare for Cancer patients, C.W. Bill Young Transplantation Program, National Cord Blood Inventory, H.R. 1230 Bone Marrow Failure Disease Research and Treatment Act of 2009, S. 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all healthcare bill, SRES 205/HCR 150 African American Bone Marrow Awareness Month, Americans Affordable Health Choices Act of 2009, American Healthy Future Act of 2009.
Client expense: $120,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Medical/Disease Research/Clinical Labs
Stem Cell Research Advancement Act (H.R. 4808) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
2010 · first_quarter · Science/Technology
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011 , biomedical research No Bill#, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act HR 3590, Patient Protection and Affordable Care Act, annual and lifetime coverage limits
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · first_quarter · Medical/Disease Research/Clinical Labs
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research No Bill#, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act HR 3590, Patient Protection and Affordable Care Act, annual and lifetime coverage limits
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · first_quarter · Budget/Appropriations
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research No Bill#, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act HR 3590, Patient Protection and Affordable Care Act, annual and lifetime coverage limits
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · first_quarter · Health Issues
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research No Bill#, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act HR 3590, Patient Protection and Affordable Care Act, annual and lifetime coverage limits
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2010 · first_quarter · Medical/Disease Research/Clinical Labs
Labor, HHS, Education Appropriations bills; hematology and hematology/oncology public health and research issues; Health Reform Legislation/HR 3200 America's Affordable Health Choices Act/HR 3590 The Patent Protection and Affordable Care Act; HR 1230 Bone Marrow Failure Disease Research and Treatment Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · fourth_quarter · Health Issues
Healthcare for cancer patients, C.W. Bill Young Transplantation Program, National Cord Blood Inventory, H.R. 1230, Bone Marrow Failure Disease Research and Treatment Act of 2009, S. 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all health care bill, SRES 205/HCR 150 African American Bone Marrow Awareness Month, Americans Affordable Health Choices Act of 2009, American Healthy Future Act of 2009.
Client expense: $60,018 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Medical/Disease Research/Clinical Labs
Stem Cell Research Enhancement Act (H.R. 873/S. 487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
Client expense: $30,000 · Firm income: Not reported
2009 · fourth_quarter · Medical/Disease Research/Clinical Labs
HR 3293, Labor-HHS-Education Appropriations Bill, FY 2010 (H.R. 3288, Consolidated Appropriations Act, 2010), biomedical research HR 3326, Defense Appropriations Bill, FY 2010, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · fourth_quarter · Science/Technology
HR 3293, Labor-HHS-Education Appropriations Bill, FY 2010 (H.R. 3288, Consolidated Appropriations Act, 2010), biomedical research HR 3326, Defense Appropriations Bill, FY 2010, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · fourth_quarter · Health Issues
HR 3293, Labor-HHS-Education Appropriations Bill, FY 2010 (H.R. 3288, Consolidated Appropriations Act, 2010), biomedical research HR 3326, Defense Appropriations Bill, FY 2010, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · fourth_quarter · Budget/Appropriations
HR 3293, Labor-HHS-Education Appropriations Bill, FY 2010 (H.R. 3288, Consolidated Appropriations Act, 2010), biomedical research HR 3326, Defense Appropriations Bill, FY 2010, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · fourth_quarter · Medical/Disease Research/Clinical Labs
FY 2010 Labor, HHS, Education Appropriations bills; hematology and hematology/oncology public health and research issues; Senate HELP & Finance Committee Health Reform Legislation/HR 3200 America's Affordable Health Choices Act/HR 3590 The Patent Protection and Affordable Care Act; HR 1230 Bone Marrow Failure Disease Research and Treatment Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · third_quarter · Health Issues
Healthcare for cancer patients, C.W. Bill Young Transplantation Program, National Cord Blood Inventory, H.R. 1230, Bone Marrow Failure Disease Research and Treatment Act of 2009, S. 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all health care bill, SRES 205/HCR 150 Af. Am. Bone Marrow Awareness Month, Americans Affordable Health Choices Act of 2009, American Healthy Future Act of 2009
Client expense: $92,157 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Medical/Disease Research/Clinical Labs
Stem Cell Research Enhancement Act (H.R.873/S.487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R.1230) Health Reform Legislation/ America's Affordable Health Choices Act of 2009 (H.R.3200) /Affordable Health Choices Act (S.1679) Physician Payments Sunshine Act (S.301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2009 · third_quarter · Budget/Appropriations
HR 3293, Labor-HHS-Education Appropriations Bill, FY 2010, biomedical research HR 3326, Defense Appropriations Bill, FY 2010, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · third_quarter · Medical/Disease Research/Clinical Labs
HR 3293, Labor-HHS-Education Appropriations Bill, FY 2010, biomedical research HR 3326, Defense Appropriations Bill, FY 2010, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · third_quarter · Health Issues
HR 3293, Labor-HHS-Education Appropriations Bill, FY 2010, biomedical research HR 3326, Defense Appropriations Bill, FY 2010, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · third_quarter · Science/Technology
HR 3293, Labor-HHS-Education Appropriations Bill, FY 2010, biomedical research HR 3326, Defense Appropriations Bill, FY 2010, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · third_quarter · Medical/Disease Research/Clinical Labs
FY 2010 Labor, HHS, Education Appropriations bills; hematology and hematology/oncology public health and research issues; Senate HELP & Finance Committee Health Reform Legislation/HR 3200 America's Affordable Health Choices Act; HR 1230 Bone Marrow Failure Disease Research and Treatment Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · second_quarter · Health Issues
C.W. Bill Young Stem Cell Therapeutic Act - issues pertaining to diversity of registry and issues pertaining to the reauthorization of the act; H.R. 716 & S. 488 concerning health plan coverage for individuals participating in cancer clinical trials. H.R. 877, concerning stem cell research; H.R. 1230, concerning the National Acquired Bone Marrow Failure Disease Registry.
Client expense: Not reported · Firm income: $30,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2009 · second_quarter · Medical/Disease Research/Clinical Labs
Stem Cell Research Enhancement Act (H.R. 873/S. 487); Embryonic Stem Cell Research; Somatic Cell Nuclear Transfer; Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research Health Reform Legislation
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
2009 · second_quarter · Health Issues
Reauthorization of C.W. Bill Young Cell Transplantation Program; National Cord Blood Inventory H.R. 1230, Bone Marrow Failure Disease Research and Treatment Act of 2009 S.Res.205 A resolution supporting the goals and ideals of African American Bone Marrow Awareness Month. H.Con.Res.150 Supporting the goals and ideals of African American Bone Marrow Awareness Month
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Budget/Appropriations
No bill, Labor-HHS-Education Appropriations Bill, FY 2010, biomedical research No bill, Defense Appropriations Bill, FY 2010, research for bone marrow failure disease H.R. 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · second_quarter · Science/Technology
No bill, Labor-HHS-Education Appropriations Bill, FY 2010, biomedical research No bill, Defense Appropriations Bill, FY 2010, research for bone marrow failure disease H.R. 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · second_quarter · Health Issues
No bill, Labor-HHS-Education Appropriations Bill, FY 2010, biomedical research No bill, Defense Appropriations Bill, FY 2010, research for bone marrow failure disease H.R. 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · second_quarter · Medical/Disease Research/Clinical Labs
No bill, Labor-HHS-Education Appropriations Bill, FY 2010, biomedical research No bill, Defense Appropriations Bill, FY 2010, research for bone marrow failure disease H.R. 1230, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2009 · second_quarter · Health Issues
Healthcare for cancer patients, C.W. Bill Young Cell Transplantation Program, National Cord Blood Inventory, H.R. 1230, Bone Marrow Failure Disease Research and Treatment Act of 2009, S. 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all health care bill, SRES 205/HCR 150 Af. Am. Bone Marrow Awareness Month.
Client expense: $89,245 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| MA |
| Baron Hill | Democratic | IN |
| Ben Chandler | Democratic | KY |
| Brad Ellsworth | Democratic | IN |
| Bruce L. Braley | Democratic | IA |
| Candice S. Miller | Republican | MI |
| Charles A. Gonzalez | Democratic | TX |
| Chris Van Hollen | Democratic | MD |
| Christopher Murphy | Democratic | CT |
| Daniel B. Maffei | Democratic | NY |
| David Loebsack | Democratic | IA |
| Diana DeGette | Democratic | CO |
| Donna M. Christensen | Democratic | VI |
| Edolphus Towns | Democratic | NY |
| Eleanor Holmes Norton | Democratic | DC |
| Eliot L. Engel | Democratic | NY |
| Emanuel Cleaver | Democratic | MO |
| Eni F. H. Faleomavaega | Democratic | AS |
| Fortney Pete Stark | Democratic | CA |
| Frank R. Wolf | Republican | VA |
| Frederick Boucher | Democratic | VA |
| G. K. Butterfield | Democratic | NC |
| Gene Green | Democratic | TX |
| James P. McGovern | Democratic | MA |
| Janice D. Schakowsky | Democratic | IL |
| Jason Altmire | Democratic | PA |
| Jim McDermott | Democratic | WA |
| Jo Ann Emerson | Republican | MO |
| Joe Sestak | Democratic | PA |
| John Barrow | Democratic | GA |
| John Conyers, Jr. | Democratic | MI |
| John Lewis | Democratic | GA |
| John Murtha | Democratic | PA |
| John W. Olver | Democratic | MA |
| Joseph R. Pitts | Republican | PA |
| Keith Ellison | Democratic | MN |
| Madeleine Z. Bordallo | Democratic | GU |
| Marcia L. Fudge | Democratic | OH |
| Mary Bono Mack | Republican | CA |
| Maurice D. Hinchey | Democratic | NY |
| Mazie K. Hirono | Democratic | HI |
| Michael Arcuri | Democratic | NY |
| Michael C. Burgess | Republican | TX |
| Michael M. Honda | Democratic | CA |
| Neil Abercrombie | Democratic | HI |
| Peter T. King | Republican | NY |
| Ralph M. Hall | Republican | TX |
| Richard E. Neal | Democratic | MA |
| Russ Carnahan | Democratic | MO |
| Sanford D. Bishop, Jr. | Democratic | GA |
| Steve Cohen | Democratic | TN |
| Tammy Baldwin | Democratic | WI |
| Thaddeus McCotter | Republican | MI |
| Tim Holden | Democratic | PA |
| Timothy H. Bishop | Democratic | NY |
| Todd Russell Platts | Republican | PA |
| Tom Latham | Republican | IA |
| Victor Snyder | Democratic | AR |
| Wm. Lacy Clay | Democratic | MO |
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), President of the U.S., SENATE